Thrombocytopenia: Mild to moderate thrombocytopenia can occur with the administration of Enoxaparin. Cases of heparin-induced thrombocytopenia with thrombosis have also been observed in clinical practices. Some of these cases were complicated by organ infarction, limb ischemia, or death.
Since Aminotransferase determinations are important in the differential diagnosis of myocardial infarction, liver disease, and pulmonary emboli, elevations that might be caused by drugs like Enoxaparin should be interpreted with caution.
Local Reaction: Mild local irritation, pain, hematoma, ecchymosis, and erythema may follow SC Enoxaparin than in patients treated with I.V. heparin.
Adverse events in Enoxaparin treated patients with unstable angina or Non-Q-wave myocardial infection: Non major hemorrhagic, primarily injection site ecchymoses and hematomas were more frequently reported in patients treated with I.V. heparin.
View ADR Reporting Link